Korean J Gastrointest Endosc.  2010 Apr;40(4):229-235.

The Benefit of Percutaneous Endoscopic Gastrostomy Is Low in Patients with Dementia

Affiliations
  • 1Department of Internal Medicine, East-West Neo Medical Center, College of Medicine, Kyung Hee University, Seoul, Korea. clicknox@hanmail.net

Abstract

BACKGROUND/AIMS
Percutaneous endoscopic gastrostomy (PEG) is beneficial in treatment of stroke or head and neck cancer. The situation for dementia is unknown. Presently, results, complications, and survival of PEG patients with or without dementia were assessed.
METHODS
In a retrospective analysis of 67 patients, gender, age, diagnosis, laboratory results, complications, tube change, early death and death were compared in dementia (n=5) and non-dementia (n=62) patients (average age 68.7 years).
RESULTS
Patient clinical characteristics were not different, except for the proportion of gender. Complications occurred in 11 cases (16.4%). Wound infection was the most common complication followed by Mallory-Weiss tear, tube leakage, fever and pneumonia. Twenty six patients (38.8%) died during the follow-up period, and the 30 day mortality rate was 2.7%. Average survival of dementia and non-dementia patients was 12 months and 25 months, respectively. Dementia patients showed a tendency for shorter survival, although it was insignificant (p=0.068). Dementia was the only predictor of mortality that showed significance (p=0.006).
CONCLUSION
In this study there was a tendency for shorter survival in dementia patients and dementia was the only significant predictor of mortality.

Keyword

Percutaneous endoscopic gastrostomy; Dementia; Survival

MeSH Terms

Clinical Laboratory Techniques
Dementia
Fever
Follow-Up Studies
Gastrostomy
Head and Neck Neoplasms
Humans
Mallory-Weiss Syndrome
Pneumonia
Retrospective Studies
Stroke
Wound Infection
Full Text Links
  • KJGE
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr